The core activity of ARTIDIS is the development and application of nanomechanical biomarkers for cancer diagnosis and treatment optimization. The company focuses on developing technologies that enable rapid and precise cancer diagnosis and predict the effectiveness of treatments. The goal is to enable a paradigm shift in cancer treatment from central laboratories to the patient's bedside.
AI-generated
Offering
Products & services
Industry:Research & DevelopmentMedical Technology Industry
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Nanomechanical profiling of fresh tumour tissue samples in the tumour microenvironment, with measurement of stiffness and deformability and preservation of tissue integrity for downstream analyses.
Artidis Research Device
Automated, AI-powered platform for atomic force microscopy with subcellular resolution, cloud analytics and high-throughput assays for research and clinical research.
Core lab services
Core-lab services for submitted samples with high-resolution biomechanical data, scientific support and flexible options for academic and industrial laboratories.
Artidisnet
Secure cloud platform for integrating nanomechanical measurements with histopathological, genomic, imaging and clinical data, as well as for real-time collaboration and analysis.
Research collaborations
Collaborations for academic researchers and industry partners for joint research, mechanobiology-driven drug development and the development of new diagnostic approaches.